Editorial & Advertiser disclosure
Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by Global Banking & Finance Review®
Posted on February 25, 2026
1 min read
Last updated: February 25, 2026
Hospital Operator Performance
Fresenius Q4 Results and Dividend Update
Feb 25 (Reuters) – German healthcare group Fresenius narrowly beat analysts’ expectations for fourth-quarter adjusted revenue on Wednesday, helped by a better performance at its hospital operator unit Helios.
Analysts’ Consensus (Vara)
Revenue vs. Analysts’ Estimates
The Hessian-based company reported quarterly revenue before special effects of 5.88 billion euros ($6.94 billion), above analysts’ average estimate of 5.8 billion euros in a Vara consensus poll.
Dividend Proposal Details
Fresenius also said it was to propose a dividend of 1.05 euros per share, above last year’s payout of 1 euro per share.
Exchange Rate Note
($1 = 0.8477 euros)
Reporting and Credits
(Reporting by Tristan Veyet in Gdansk, Patricia Weiss in Frankfurt, editing by Milla Nissi-Prussak)